MedTrace Logo

The Effect of Alginate Supplementation on Weight Management

NCT04589273 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2023-06-01

No results posted yet for this study

Summary

This project will assess the effect of the alginate (in a capsules) on the weight of generally healthy volunteers over a 12 week period.

To achieve this, will recruit 150 (non-smoking) generally healthy volunteers to attend the study centre on four separate occasions. Volunteers will be randomly allocated into active or placebo arm of the trial, both will receive capsules with the same appearance.

The volunteers will have their height, weight, waist circumference, body composition, and fasting levels of circulating glucose, triacylglycerol and cholesterol measured at each for the four visits.

Conditions

  • Overweight and Obesity

Interventions

DIETARY_SUPPLEMENT

Alginate

Volunteers will be asked to consume the alginate capsules with each of their three main meals per day.

OTHER

Placebo

Volunteers will be asked to consume the placebo capsules with each of their three main meals per day.

Sponsors & Collaborators

  • Newcastle University

    lead OTHER

Principal Investigators

  • Pearson · Newcastle University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-19
Primary Completion
2023-10-31
Completion
2023-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04589273 on ClinicalTrials.gov